Filana Therapeutics, Inc. (FLNA)
Healthcare
Biotechnology
1.00 $
+2.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Filana Therapeutics, Inc. (FLNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -78 | -82 | -117 | -32 | |
| 1.3 | 1.5 | 1.1 | 0.9 | |
| 2.1 | 4.6 | 16 | 20 | |
| -4.6 | 9.1 | -1.8 | 38 | |
| 2.7 | 0.4 | 0.1 | 0.6 | |
| – | – | – | -0.6 | |
| 48 | 2.6 | 124 | -0.2 | |
| -32 | -80 | 7.4 | -33 | |
| -80 | -82 | -117 | -33 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.